Cited by 2,012Gut microbiota and healthTryptophan and brain disordersGastrointestinal motility and disorders

The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

O’Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F.·2015·Behavioural Brain Research

Abstract

The brain-gut axis is a bidirectional communication system between the central nervous system and the gastrointestinal tract. Serotonin functions as a key neurotransmitter at both terminals of this network. Accumulating evidence points to a critical role for the gut microbiome in regulating normal functioning of this axis. In particular, it is becoming clear that the microbial influence on tryptophan metabolism and the serotonergic system may be an important node in such regulation. There is also substantial overlap between behaviours influenced by the gut microbiota and those which rely on intact serotonergic neurotransmission. The developing serotonergic system may be vulnerable to differential microbial colonisation patterns prior to the emergence of a stable adult-like gut microbiota. At the other extreme of life, the decreased diversity and stability of the gut microbiota may dictate serotonin-related health problems in the elderly. The mechanisms underpinning this crosstalk require further elaboration but may be related to the ability of the gut microbiota to control host tryptophan metabolism along the kynurenine pathway, thereby simultaneously reducing the fraction available for serotonin synthesis and increasing the production of neuroactive metabolites. The enzymes of this pathway are immune and stress-responsive, both systems which buttress the brain-gut axis. In addition, there are neural processes in the gastrointestinal tract which can be influenced by local alterations in serotonin concentrations with subsequent relay of signals along the scaffolding of the brain-gut axis to influence CNS neurotransmission. Therapeutic targeting of the gut microbiota might be a viable treatment strategy for serotonin-related brain-gut axis disorders.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.bbr.2014.07.027

Cites

246 of 246 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 246 references

Research works printed but not linked: 5

  1. Shishov, 2009, [Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12], Prikladnaia biokhimiia i mikrobiologiia, 45, 550
  2. Clarke, 2014, Priming for health: the gut microbiota acquired early in life regulates physiology, Brain Behav Acta Paediatrica, 10.1111/apa.12674 · DOI · Paper page
  3. Clarke, 2014, Gut microbiota: the neglected endocrine organ, Mol Endocrinol, me20141108
  4. Wall, 2009, Role of gut microbiota in early infant development, Clin Med Pediatr, 3, 45, 10.4137/CMPed.S2008 · DOI
  5. O’Mahony, 2010, Early-life dysbiosis-induced visceral hypersensitivity in adulthood, Gastroenterology, 138, S4

Cited by

Sorted by citations

Items 101–131 of 131

Metadata

Authors
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F.
Affiliations
University College Cork (IE)
Corresponding author
Clarke, G.
Venue
Behavioural Brain Research
Publisher
Elsevier BV
Published
2015-01
Volume
277
Pages
32-48
ISSN
0166-4328 (ISSN-L)
OpenAlex
W1972237932
Cited by
2,012
References
246
Citations by year
2026: 185 · 2025: 225 · 2024: 246 · 2023: 211 · 2022: 214 · 2021: 222 · 2020: 199 · 2019: 163 · 2018: 122 · 2017: 104 · 2016: 73 · 2015: 41
FWCI
6.87
Type
journal article
Language
en
Open access
closed
Locations
  • Behavioural Brain Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Health Research Board (HRA_POR/2011/23, HRA_POR/2012/32)
  • Science Foundation Ireland (02/CE/B124, 07/CE/B1368, SFI/12/RC/2273)
  • Seventh Framework Programme (201 714, FP7/2007–2013)
  • Brain and Behavior Research Foundation (20771)
  • National Alliance for Research on Schizophrenia and Depression
  • GlaxoSmithKline
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
serotonin, tryptophan metabolism, gut-brain axis, gut microbiota, kynurenine pathway, serotonergic system, neuroactive metabolites, gut-brain signaling, microbial colonization, gut microbiota diversity, neuroimmune interactions, stress response
MeSH terms
Animals, Behavior, Brain, Humans, Serotonin, Tryptophan, Gastrointestinal Tract, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review